Inventor · disambiguated record
Florian Sennlaub
Also filed as: SENNLAUB FLORIAN
10 granted patents·6 pending applications·16 citations·filing 2001–2021
82Inventor score
Files withUNIV SORBONNE5UNIV PIERRE ET MARIE CURIE PARIS 62VALORISATION-RECHERCHE LTD PARTNERSHIP2BERNARD ROMAIN1COMBADIERE CHRISTOPHE1
Top patents by PatentIndex Score
16 records- 0182US9434766B2CCR2 antagonist peptidesCOMBADIERE CHRISTOPHE·Filed 2012·Granted Sep 6, 2016·11 cites·6 claims
- 0274US9115171B2Azapeptides as CD36 binding compoundsVALORISATION RECHERCHE LTD PARTNERSHIP·Filed 2013·Granted Aug 25, 2015·3 cites·14 claims
- 0365US8435954B2Azapeptides as CD36 binding compoundsONG HUY·Filed 2008·Granted May 7, 2013·1 cites·2 claims
- 0464US10519232B2Agents for use in the treatment of retinal inflammationUNIV SORBONNE·Filed 2015·Granted Dec 31, 2019·1 cites·8 claims
- 0557US10253087B2CCR2 antagonist peptidesUNIV PIERRE ET MARIE CURIE PARIS 6·Filed 2018·Granted Apr 9, 2019·0 cites·7 claims
- 0654US2023172919A1An insulin sensitizer for use in the prevention and/or treatment of the damages caused by retinal detachmentUNIV SORBONNE·Filed 2021·Application pending·0 cites
- 0751US2006031946A1Gene therapy with chimeric oligonucleotides delivered by a method comprising a step of iontophoresisINST NAT SANTE RECH MED·Filed 2004·Application pending·0 cites
- 0849US2011135661A1Treatment and prevention of dry age-related macular degeneration by activating cd36UNIV MONTREAL·Filed 2009·Application pending·0 cites
- 0948US11072661B2Agents that inhibit the binding of CFH to CD11 b/CD18 and uses thereofUNIV SORBONNE·Filed 2016·Granted Jul 27, 2021·0 cites·6 claims
- 1047US2017051040A1Ccr2 antagonist peptidesUNIV PIERRE ET MARIE CURIE PARIS 6·Filed 2016·Application pending·0 cites
- 1144US9708370B2Azapeptides as CD36 binding compoundsVALORISATION-RECHERCHE LTD PARTNERSHIP·Filed 2015·Granted Jul 18, 2017·0 cites·20 claims
- 1242US8603964B2Methods for modulating angiogenesis via dystrophin Dp71BERNARD ROMAIN·Filed 2009·Granted Dec 10, 2013·0 cites·6 claims
- 1342US2003045830A1Gene therapy with chimeric oligonucleotides delivered by a method comprising a step of iontophoresisFiled 2001·Application pending·0 cites
- 1441US11142548B2Agents that activate CD47 and their use in the treatment of inflammationUNIV SORBONNE·Filed 2017·Granted Oct 12, 2021·0 cites·5 claims
- 1541US2009088721A1Enhanced retinal delivery of a nucleic acid through iontophoresisEYEGATE PHARMA S A S·Filed 2007·Application pending·0 cites
- 1633US11191807B2Lebecetin, a C-type lectin, as neovascularization inhibitorUNIV SORBONNE·Filed 2017·Granted Dec 7, 2021·0 cites·18 claims
Join the waitlist — get patent alerts
Get an alert when Florian Sennlaub files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →